<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10903</article-id><article-id pub-id-type="doi">10.7554/eLife.10903</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genes and Chromosomes</subject></subj-group></article-categories><title-group><article-title>Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-40188"><name><surname>Chellappa</surname><given-names>Karthikeyani</given-names></name><aff><institution content-type="dept">Institute for Diabetes, Obesity, and Metabolism, Department of Physiology, Perelman School of Medicine</institution>, <institution>University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40861"><name><surname>Deol</surname><given-names>Poonamjot</given-names></name><aff><institution content-type="dept">Department of Cell Biology and Neuroscience</institution>, <institution>University of California, Riverside</institution>, <addr-line><named-content content-type="city">Riverside</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47513"><name><surname>Evans</surname><given-names>Jane R</given-names></name><aff><institution content-type="dept">Department of Cell Biology and Neuroscience</institution>, <institution>University of California, Riverside</institution>, <addr-line><named-content content-type="city">Riverside</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47514"><name><surname>Vuong</surname><given-names>Linh M</given-names></name><aff><institution content-type="dept">Department of Cell Biology and Neuroscience</institution>, <institution>University of California, Riverside</institution>, <addr-line><named-content content-type="city">Riverside</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40863"><name><surname>Chen</surname><given-names>Gang</given-names></name><aff><institution content-type="dept">Division of Biomedical Sciences</institution>, <institution>University of California, Riverside</institution>, <addr-line><named-content content-type="city">Riverside</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40864"><name><surname>Briançon</surname><given-names>Nadege</given-names></name><aff><institution content-type="dept">Department of Cell Biology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40865"><name><surname>Bolotin</surname><given-names>Eugene</given-names></name><aff><institution content-type="dept">Department of Cell Biology and Neuroscience</institution>, <institution>University of California, Riverside</institution>, <addr-line><named-content content-type="city">Riverside</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40866"><name><surname>Lytle</surname><given-names>Christian</given-names></name><aff><institution content-type="dept">Division of Biomedical Sciences</institution>, <institution>University of California, Riverside</institution>, <addr-line><named-content content-type="city">Riverside</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40867"><name><surname>Nair</surname><given-names>Meera G</given-names></name><aff><institution content-type="dept">Division of Biomedical Sciences</institution>, <institution>University of California, Riverside</institution>, <addr-line><named-content content-type="city">Riverside</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-40281"><name><surname>Sladek</surname><given-names>Frances M</given-names></name><aff><institution content-type="dept">Department of Cell Biology and Neuroscience</institution>, <institution>University of California Riverside</institution>, <addr-line><named-content content-type="city">Riverside</named-content></addr-line>, <country>United States</country><email>frances.sladek@ucr.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1189"><name><surname>Struhl</surname><given-names>Kevin</given-names></name><role>Reviewing editor</role><aff><institution>Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>11</day><month>05</month><year>2016</year></pub-date><elocation-id>e10903</elocation-id><supplementary-material><ext-link xlink:href="elife-10903-supp-v2.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>15</day><month>08</month><year>2015</year></date><date date-type="accepted"><day>09</day><month>05</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Chellappa et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Chellappa et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>HNF4α has been implicated in colitis and colon cancer in humans but the role of the different HNF4α isoforms expressed from the two different promoters (P1 and P2) active in the colon is not clear. Here, we show that P1-HNF4α is expressed primarily in the differentiated compartment of the mouse colonic crypt and P2-HNF4α in the proliferative compartment. Exon swap mice that express only P1- or only P2-HNF4α have different colonic gene expression profiles, interacting proteins, cellular migration, ion transport and epithelial barrier function. The mice also exhibit altered susceptibilities to experimental colitis (DSS) and colitis-associated colon cancer (AOM+DSS). When P2-HNF4α-only mice (which have elevated levels of the cytokine resistin-like β, RELMβ, and are extremely sensitive to DSS) are crossed with <italic>Retnlb<sup>-/-</sup></italic> mice, they are rescued from mortality. Furthermore, P2-HNF4α binds and preferentially activates the RELMβ promoter. In summary, HNF4α isoforms perform non-redundant functions in the colon under conditions of stress, underscoring the importance of tracking them both in colitis and colon cancer.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Care and treatment of animals were in strict accordance with guidelines from the University of California Riverside Institutional Animal Care and Use Committee. Institutional protocol number A200140014.</p></fn></fn-group></back></article>